Vitamin D May Slow Progression of Multiple Sclerosis
A recent Harvard study found that high blood levels of vitamin D may be associated with slower progression and reduced disease activity in people with multiple sclerosis (MS).
Participants in the study included 465 participants in the BENEFIT study. The researchers measured blood levels of vitamin D and followed up for five years with magnetic resonance imaging (MRI).
The researchers found that increasing blood levels of vitamin D by 50 nmol/L in the first 12 months was associated with a 57% lower risk of new active brain lesions, 57% lower risk of relapse, 25% lower yearly increase in T2 lesion volume and 0.41% lower yearly loss in brain volume.
These findings are significant because MS is often associated with neurological disability.
The study was published on January 20, 2014, in JAMA Neurology.
Previous studies have associated vitamin D with reducing the risk of skin cancer, reducing the risk of osteoporosis, combating diabetes, and improving age related macular degeneration.
Vitamin D can be found in milk, fortified cereals, fish, and eggs. Your body also processes vitamin D from the sun but it becomes harder for our bodies to process it as we age. A high quality vitamin D supplement is always a good option if you feel that you’re not getting enough through diet and sun.